HOUSE 4402118th CongressReferred to the Subcommittee on Health.
To amend title XI of the Social Security Act to clarify manufacturer transparency reporting requirements for certain transfers used for educational purposes.
- Last Action
- 12/17/2024
Actions
- 2024-12-17Referred to the Subcommittee on Health.
- 2023-07-07Referred to the Subcommittee on Health.
- 2023-06-30Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2023-06-30Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2023-06-30Introduced in House
- 2023-06-30Introduced in House
CRS Summary
As of 2023-06-30 (00)
This bill specifies that manufacturers of drugs, devices, biologics, or medical supplies covered by Medicare, Medicaid or the Children's Health Insurance Program (CHIP) are not required to report peer-reviewed journals, journal reprints, journal supplements, medical conference reports, or medical textbooks that are provided to health care practitioners or teaching hospitals.
Cosponsors (1)
- Ami Bera (D-CA)
Subjects
- Health technology, devices, supplies
- Manufacturing
- Medicaid
- Medicare
- Poverty and welfare assistance
- Prescription drugs
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.